Anti-leucine-rich glioma-inactivated 1-positive limbic encephalitis presenting hypothalamic symptoms
- 1 June 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Neurological Sciences
- Vol. 41 (6), 1595-1597
- https://doi.org/10.1007/s10072-019-04202-w
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- The immunobiology of autoimmune encephalitidesJournal of Autoimmunity, 2019
- LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizuresSeizure, 2017
- Cramp‐fasciculation syndrome in patients with and without neural autoantibodiesMuscle & Nerve, 2013
- The diagnosis and treatment of limbic encephalitisActa Neurologica Scandinavica, 2012
- Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitisAnnals of Neurology, 2010
- Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotoniaBrain, 2010
- Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigenThe Lancet Neurology, 2009
- Limbic Encephalitis and Variants: Classification, Diagnosis and TreatmentThe Neurologist, 2007
- Paraneoplastic limbic encephalitis: clinico-pathological correlations.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- “LIMBIC ENCEPHALITIS” AND ITS ASSOCIATION WITH CARCINOMABrain, 1968